CSL Reports $2.6 Billion Net Loss Amid Restructuring, Lower US Flu Vaccination Rates

The company reported revenue of US$15.8 billion for 2025-26; however, one-off restructuring costs and impairments resulted in a net loss of US$2.6 billion.